Erbitux (cetuximab) - Eli Lilly, EMD Serono
BND-22 - Biond Biologics, Sanofi
Keytruda (pembrolizumab) - Merck (MSD)
https://cslide.ctimeetingtech.com/immuno23hybrid/attendee/confcal/show/session/34
 
Ruth Perets 1; S. Stemmer 2; R. Geva 3; T. Golan 4; M. Fakih 5; J. Cohen 6; C. Lieu 7; Z. Jin 8; P. Lorusso 9; N. Ashtamker 10; I. Friedman 11; M. Hakim10; N. Crawford 12; R. Perez 12; M. Agarwal 13; G. Abbadessa 13; M. Wu 13; J. Lin 13; C. Deantonio 14; M. Borad 15
 
Oct 23, 2023
 
Prev Next